Arvinas (ARVN) Payables (2017 - 2026)
Arvinas (ARVN) recorded quarterly Payables of $62.3 million in Q1 2026, down 10.36% quarter-over-quarter from $69.5 million in Q4 2025, and down 12.38% on a YoY basis from $71.1 million in Q1 2025.
Arvinas (ARVN) Payables (2017 - 2026) Analysis & Trends
Arvinas' Payables history runs 10 years deep, the most recent figure standing at $62.3 million for Q1 2026.
- In Q1 2026, Payables fell 12.38% year-over-year to $62.3 million; the TTM figure through Mar 2026 stood at $62.3 million (down 12.38% YoY), while the FY2025 annual figure was $69.5 million, down 3.2% from the prior year.
- Payables was $62.3 million for Q1 2026 at Arvinas, down from $69.5 million in the prior quarter.
- In the past five years, Payables ranged from a high of $92.2 million in Q4 2023 to a low of $8.6 million in Q1 2022.
- Historically, Payables has averaged $65.5 million across 5 years, with a median of $71.1 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Payables jumped 963.87% in 2022, then tumbled 32.01% in 2025.
- A 5-year view of Payables shows it stood at $74.7 million in 2022, then increased by 23.43% to $92.2 million in 2023, then decreased by 22.13% to $71.8 million in 2024, then fell by 3.2% to $69.5 million in 2025, then fell by 10.36% to $62.3 million in 2026.
- The last three Payables figures came in at $62.3 million (Q1 2026), $69.5 million (Q4 2025), and $55.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 62.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.30 Mn |
| Dec 31, 2025 | 69.50 Mn |
| Sep 30, 2025 | 55.50 Mn |
| Jun 30, 2025 | 53.10 Mn |
| Mar 31, 2025 | 71.10 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 75.90 Mn |
| Jun 30, 2024 | 78.10 Mn |
| Mar 31, 2024 | 76.40 Mn |
| Dec 31, 2023 | 92.20 Mn |
| Sep 30, 2023 | 91.00 Mn |
| Jun 30, 2023 | 74.80 Mn |
| Mar 31, 2023 | 66.00 Mn |
| Dec 31, 2022 | 74.70 Mn |
| Sep 30, 2022 | 49.70 Mn |
| Jun 30, 2022 | 42.10 Mn |
| Mar 31, 2022 | 8.60 Mn |
| Dec 31, 2021 | 54.40 Mn |
| Sep 30, 2021 | 4.67 Mn |
| Jun 30, 2021 | 4.98 Mn |